Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS J ; 285(20): 3849-3869, 2018 10.
Article in English | MEDLINE | ID: mdl-30120904

ABSTRACT

We characterize Rv0474, a putative transcriptional regulatory protein of Mycobacterium tuberculosis, which is found to function as a copper-responsive transcriptional regulator at toxic levels of copper. It is an autorepressor, but at elevated levels (10-250 µm) of copper ions the repression is relieved resulting in an increase in Rv0474 expression. Copper-bound Rv0474 is recruited to the rpoB promoter leading to its repression resulting in the growth arrest of the bacterium. Mutational analysis showed that the helix-turn-helix and leucine zipper domains of Rv0474 are essential for its binding to Rv0474 and rpoB promoters, respectively. The mechanism of Rv0474-mediated rpoB regulation seems to be operational only in pathogenic mycobacteria that can persist inside the host.


Subject(s)
Bacterial Proteins/genetics , Copper/pharmacology , DNA-Directed RNA Polymerases/genetics , DNA-Directed RNA Polymerases/metabolism , Gene Expression Regulation, Bacterial/drug effects , Mycobacterium tuberculosis/metabolism , Transcription Factors/genetics , Amino Acid Sequence , Bacterial Proteins/metabolism , Humans , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/growth & development , Promoter Regions, Genetic , Sequence Homology , THP-1 Cells , Transcription Factors/metabolism , Transcription, Genetic
2.
J Biol Chem ; 292(24): 10197-10219, 2017 06 16.
Article in English | MEDLINE | ID: mdl-28446609

ABSTRACT

The gp120 subunit of the HIV-1 envelope (Env) protein is heavily glycosylated at ∼25 glycosylation sites, of which ∼7-8 are located in the V1/V2 and V3 variable loops and the others in the remaining core gp120 region. Glycans partially shield Env from recognition by the host immune system and also are believed to be indispensable for proper folding of gp120 and for viral infectivity. Previous attempts to alter glycosylation sites in Env typically involved mutating the glycosylated asparagine residues to structurally similar glutamines or alanines. Here, we confirmed that such mutations at multiple glycosylation sites greatly diminish viral infectivity and result in significantly reduced binding to both neutralizing and non-neutralizing antibodies. Therefore, using an alternative approach, we combined evolutionary information with structure-guided design and yeast surface display to produce properly cleaved HIV-1 Env variants that lack all 15 core gp120 glycans, yet retain conformational integrity and multiple-cycle viral infectivity and bind to several broadly neutralizing antibodies (bNAbs), including trimer-specific antibodies and a germline-reverted version of the bNAb VRC01. Our observations demonstrate that core gp120 glycans are not essential for folding, and hence their likely primary role is enabling immune evasion. We also show that our glycan removal approach is not strain restricted. Glycan-deficient Env derivatives can be used as priming immunogens because they should engage and activate a more divergent set of germlines than fully glycosylated Env. In conclusion, these results clarify the role of core gp120 glycosylation and illustrate a general method for designing glycan-free folded protein derivatives.


Subject(s)
HIV Envelope Protein gp120/metabolism , HIV-1/metabolism , Immune Evasion , Models, Molecular , Protein Processing, Post-Translational , Amino Acid Substitution , Antibodies, Neutralizing/metabolism , Antibodies, Viral , Antibody Specificity , Asparagine/metabolism , Glycosylation , HIV Envelope Protein gp120/antagonists & inhibitors , HIV Envelope Protein gp120/chemistry , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp41/antagonists & inhibitors , HIV Envelope Protein gp41/chemistry , HIV Envelope Protein gp41/metabolism , HIV-1/immunology , HIV-1/pathogenicity , Humans , Mutagenesis, Site-Directed , Mutation , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Conformation , Protein Engineering , Protein Folding , Protein Multimerization , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism
3.
Asian J Psychiatr ; 24: 99-102, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27931919

ABSTRACT

Inflammation, dyslipidemia and altered copper levels have been reported in several psychiatric disorders, including schizophrenia. However, their association with the severity of psychopathology in schizophrenia is yet to be established. The present study was designed to assess the serum levels of copper, highly sensitive C-reactive protein (hs-CRP) and lipid profile and to explore their association with psychopathology scores in schizophrenia. 40 cases and 40 controls were included in the study. Serum copper, hs-CRP and lipid profile were estimated in all the subjects. Disease severity was assessed using Positive and Negative Syndrome Scale (PANSS). Copper, hs-CRP, total cholesterol and LDL-Cholesterol were significantly increased and HDL-Cholesterol was significantly reduced in schizophrenia cases when compared with controls. Copper was positively correlated with hs-CRP (r=0.338, p=0.003). Total cholesterol was significantly correlated with PANSS total (r=0.452, p=0.003) and negative symptom scores (r=0.337, p=0.033). Triacylglycerol was positively correlated with general psychopathology symptom score (r=0.416, p=0.008). Copper and hs-CRP were increased and correlated well with each other in schizophrenia cases. Though total cholesterol and triacylglycerol showed positive association with severity of the psychopathology, copper and hs-CRP were not associated with the disease severity.


Subject(s)
C-Reactive Protein/analysis , Copper/blood , Dyslipidemias/blood , Schizophrenia/blood , Schizophrenia/physiopathology , Adult , Case-Control Studies , Female , Humans , Male , Severity of Illness Index , Young Adult
4.
Clin Chem Lab Med ; 54(3): 447-52, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26351924

ABSTRACT

BACKGROUND: Deregulation of synaptic plasticity and oxidative stress are reported to play a crucial role in the pathogenesis of schizophrenia. Matrix metalloproteinase-9 (MMP-9) is an extracellular protease involved in regulation of synaptic plasticity. Malondialdehyde (MDA) is a marker of lipid peroxidation which is elevated in schizophrenia. Earlier studies have reported polymorphism of MMP-9 and its association with schizophrenia. The present study was designed to assess the serum levels of MMP-9, MDA and total antioxidant status (TAS) and their association in schizophrenia. METHODS: A total of 40 cases and 40 controls were included in the study. Serum MMP-9, MDA and TAS were estimated in all the subjects. Disease severity was assessed using Positive and Negative Syndrome Scale (PANSS). RESULTS: MMP-9 and MDA were significantly increased and TAS were significantly reduced in schizophrenia cases compared to controls. MMP-9 was positively correlated with MDA (r=0.353, p=0.025) and negatively correlated with TAS (r=-0.461, p=0.003). TAS was significantly correlated with total (r=0.322, p=0.043) and negative symptom scores (r=0.336, p=0.034). Higher MMP-9 levels were associated with previous exposure to antipsychotics (p=0.032). CONCLUSIONS: MMP-9 and oxidative stress were increased and correlate well with each other in schizophrenia cases. Though total oxidant status showed positive association with disease severity, MMP-9 and MDA were not associated with the severity of the disease.


Subject(s)
Matrix Metalloproteinase 9/blood , Oxidative Stress , Schizophrenia/blood , Schizophrenia/enzymology , Adult , Case-Control Studies , Humans , Linear Models , Male , Malondialdehyde/blood , Models, Biological , Schizophrenia/physiopathology
5.
Elife ; 42015 Dec 30.
Article in English | MEDLINE | ID: mdl-26716404

ABSTRACT

Identification of residue-residue contacts from primary sequence can be used to guide protein structure prediction. Using Escherichia coli CcdB as the test case, we describe an experimental method termed saturation-suppressor mutagenesis to acquire residue contact information. In this methodology, for each of five inactive CcdB mutants, exhaustive screens for suppressors were performed. Proximal suppressors were accurately discriminated from distal suppressors based on their phenotypes when present as single mutants. Experimentally identified putative proximal pairs formed spatial constraints to recover >98% of native-like models of CcdB from a decoy dataset. Suppressor methodology was also applied to the integral membrane protein, diacylglycerol kinase A where the structures determined by X-ray crystallography and NMR were significantly different. Suppressor as well as sequence co-variation data clearly point to the X-ray structure being the functional one adopted in vivo. The methodology is applicable to any macromolecular system for which a convenient phenotypic assay exists.


Subject(s)
Bacterial Proteins/chemistry , Diacylglycerol Kinase/chemistry , Escherichia coli/enzymology , Mutagenesis , Suppression, Genetic , Bacterial Proteins/genetics , Diacylglycerol Kinase/genetics , Escherichia coli/chemistry , Escherichia coli/genetics , Models, Molecular , Protein Conformation
SELECTION OF CITATIONS
SEARCH DETAIL
...